The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
A Potential Biomarker For The Early Detection Of Ebola
Researchers have found an microRNA-like fragment that is detectable in infected patients but not during recovery—suggesting that it could serve as a biomarker for the disease.
Brain Cancer Linked To A Lack Of RNA Editing
Insufficient RNA editing in brain tissues could drive the growth of aggressive tumors, scientists say.
WuXi STA & Regulus To Collaborate On MicroRNA-Targeting Drugs
The partnership is aimed at accelerating Regulus’ oligonucleotide therapeutics programs into the clinic for the treatment of a variety of diseases.
How Immune Cells Help Wire The Brain
Contrary to the general consensus that the brain is an immune privileged site, researchers have shown that a specific group of immune cells are required for the maturation of neurons.
Genetically Diverse Trees Support A Wider Range Of Insects
A research group in Japan has identified correlations between the genetic diversity of a tree species and its constituent insect communities.
Bacterial Species That Alleviate Diabetes Identified
A research group in China has identified a group of gut microbiota that can alleviate the symptoms of type 2 diabetes in patients consuming a diet high in fiber.
Plants Activate ‘Self-Eating’ Pathways When Hungry
Scientists have discovered that plants depend on autophagy to sustain themselves during starvation conditions, such as when there is insufficient sunlight.
Six Steps To Turn Stem Cells Into Liver Cells
Scientists have devised a method to generate large numbers of pure liver cells from stem cells.
Precision Drug Release With Pumpkin-Shaped Molecules
Scientists have developed light-responsive molecules for the controlled release of chemotherapy drugs to cancer cells.